← Back to Company DatabaseVisit Website
Burning Rock Biotech
Next-generation sequencing-based cancer diagnostics in China.
PublicGuangzhou, ChinaFounded 2014
About
Burning Rock Biotech is a leading cancer diagnostics company in China that uses NGS technology for tumor profiling and early cancer detection. The company offers companion diagnostics and minimal residual disease monitoring for oncology. It is also developing multi-cancer early detection blood tests leveraging methylation analysis.
Total Funding
$390MKey Product
OncoScreen Plus tumor profiling panelGeography
Asia PacificKey Investors
Sequoia Capital ChinaGICLYFE Capital
Focus Areas
Early Detection / ScreeningDiagnostics
Technology
Genomics / SequencingLiquid BiopsyAI / Machine Learning
Cancer Types
LungPan-cancer
Last updated: Feb 4, 2026